314 related articles for article (PubMed ID: 19036098)
1. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
[TBL] [Abstract][Full Text] [Related]
3. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
4. Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors.
Petterson T; Jendholm J; Månsson A; Bjartell A; Riesbeck K; Cardell LO
J Leukoc Biol; 2011 Feb; 89(2):177-87. PubMed ID: 20844241
[TBL] [Abstract][Full Text] [Related]
5. Expression of functional Toll-like receptors and nucleotide-binding oligomerization domain proteins in murine cementoblasts and their upregulation during cell differentiation.
Nemoto E; Honda T; Kanaya S; Takada H; Shimauchi H
J Periodontal Res; 2008 Oct; 43(5):585-93. PubMed ID: 18565134
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection.
Lester RT; Yao XD; Ball TB; McKinnon LR; Kaul R; Wachihi C; Jaoko W; Plummer FA; Rosenthal KL
AIDS; 2008 Mar; 22(6):685-94. PubMed ID: 18356597
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation.
Uehara A; Iwashiro A; Sato T; Yokota S; Takada H
Mol Immunol; 2007 Jul; 44(14):3552-62. PubMed ID: 17452051
[TBL] [Abstract][Full Text] [Related]
9. NOD2 receptors in adenopituitary folliculostellate cells: expression and function.
Correa-de-Santana E; Fröhlich B; Labeur M; Páez-Pereda M; Theodoropoulou M; Monteserin JL; Renner U; Stalla GK
J Endocrinol; 2009 Oct; 203(1):111-22. PubMed ID: 19608614
[TBL] [Abstract][Full Text] [Related]
10. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
Le Bourhis L; Benko S; Girardin SE
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
[TBL] [Abstract][Full Text] [Related]
11. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
12. Synergistic enhancement of Toll-like receptor responses by NOD1 activation.
van Heel DA; Ghosh S; Butler M; Hunt K; Foxwell BM; Mengin-Lecreulx D; Playford RJ
Eur J Immunol; 2005 Aug; 35(8):2471-6. PubMed ID: 16021603
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.
Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R
Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493
[TBL] [Abstract][Full Text] [Related]
14. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
15. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Nod1 and Nod2 in first trimester trophoblast cells.
Mulla MJ; Yu AG; Cardenas I; Guller S; Panda B; Abrahams VM
Am J Reprod Immunol; 2009 Apr; 61(4):294-302. PubMed ID: 19260860
[TBL] [Abstract][Full Text] [Related]
17. Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts.
Hirao K; Yumoto H; Takahashi K; Mukai K; Nakanishi T; Matsuo T
J Dent Res; 2009 Aug; 88(8):762-7. PubMed ID: 19734466
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
Hammadi A; Billard C; Faussat AM; Kolb JP
Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
[TBL] [Abstract][Full Text] [Related]
19. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells.
Bérubé J; Bourdon C; Yao Y; Rousseau S
Cell Signal; 2009 Mar; 21(3):448-56. PubMed ID: 19121387
[TBL] [Abstract][Full Text] [Related]
20. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
